Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.93
+0.25001.06%
Volume:392
Turnover:9.34K
Market Cap:4.79M
PE:- -
High:23.93
Open:23.78
Low:23.78
Close:23.68
52wk High:24.29
52wk Low:15.67
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.63
T/O Rate:0.20%
Dividend:0.77
Dividend Rate:3.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna appoints Juan Andres as COO

TIPRANKS
·
Sep 30

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

TIPRANKS
·
Sep 30

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Sep 30

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

THOMSON REUTERS
·
Sep 30

Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website

THOMSON REUTERS
·
Sep 30

Moderna Appoints Juan Andres as Chief Operating Officer

Reuters
·
Sep 30

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Dow Jones
·
Sep 30

Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60

THOMSON REUTERS
·
Sep 30

Moderna sinks 4% to $195.42 after Citi downgrades to Sell

TIPRANKS
·
Sep 30

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

Stock News
·
Sep 30

Eli Lilly reports results from TRIUMPH-2 Phase 3 trial

TIPRANKS
·
Sep 30

Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial

Reuters
·
Sep 30

Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks

THOMSON REUTERS
·
Sep 30

Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes

THOMSON REUTERS
·
Sep 30

Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027

THOMSON REUTERS
·
Sep 30

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS
·
Sep 30

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Dow Jones
·
Sep 30

Twist Bioscience (TWST) Gets a Buy from Leerink Partners

TIPRANKS
·
Sep 29

Eli Lilly Reports Zepbound Showed 4.5% Greater Weight Loss Than Novo Nordisk's Wegovy HD

MT Newswires Live
·
Sep 29

Eli Lilly’s Zepbound shows improved weight loss vs. Wegovy in new analysis

TIPRANKS
·
Sep 29